By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



3388 Mike Collins Drive

Eagan  Minnesota  55121  U.S.A.
Phone: 651-675-0300 Fax: 651-675-0400



Company News
Biothera To Present Additional Data To The American Association Of Immunologists On Imprime PGG's Potential To Alleviate Tumor-Mediated Immunosuppression 5/8/2015 11:57:47 AM
Biothera’s Investigational Cancer Immunotherapy Alleviates Immune Suppression By Regulatory T Cells, Enabling CD4 And CD8 T Cell Proliferation, Study Finds 4/22/2015 8:45:21 AM
Biothera’s Investigational Cancer Immunotherapy Drug Imprime PGG Elicits Dramatic Expansion Of Cytotoxic T Cells 4/21/2015 3:43:33 PM
New Data Demonstrate Potential Of Biothera’s Investigational Cancer Immunotherapy To Re-Orient The Tumor Microenvironment To Facilitate Greater Anti-Tumor Activity 4/21/2015 3:42:38 PM
Biothera’s Imprime PGG Investigational Immunotherapy Drug Modulates The Function Of Macrophages And Dendritic Cells To Drive Expansion Of Anti-Cancer T Cells 4/21/2015 3:41:17 PM
Biothera’s Imprime PGG Cancer Immunotherapy Drug Candidate Shows Potential To Enhance Efficacy Of Immune Checkpoint Inhibitors 4/21/2015 3:40:09 PM
Biothera Immunotherapy Combination Results In Tumor Reduction During Maintenance Phase Of Non-Small Cell Lung Cancer Study 4/15/2015 8:36:48 AM
Biothera To Present Three Late-Breaking Posters At The American Association for Cancer Research Annual Meeting 4/9/2015 10:10:45 AM
Biothera To Participate In Novel Immunomodulatory Therapies Panel Discussion At Cancer Progress Conference 3/16/2015 10:52:47 AM
Biothera's Investigational Cancer Immunotherapy Imprime PGG Neutralizes Cancer Defense Mechanisms In The Tumor Mircoenvironment 3/9/2015 9:55:38 AM